Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

602 Articles

Chris Lange | Jul 23, 2015 at 1:25 PM EDT

What to Expect From AbbVie Earnings

Abbvie is scheduled to report its second-quarter financial results before the markets open Friday.

Paul Ausick | Jul 20, 2015 at 9:35 AM EDT

Top Health Care Earnings for the Week Ahead

Earnings season is hitting its stride next week, and the health care sector, the biotech stocks in particular, have been…

Lee Jackson | Jul 14, 2015 at 10:20 AM EDT

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

A new report from Jefferies updates the firm's top global pharmaceutical stocks to buy, and these picks make sense for…

Chris Lange | Jul 13, 2015 at 8:05 AM EDT

Short Sellers Run for Cover in Big Pharma

The June 30 short interest data have been compared with the previous figures, and across the selected pharmaceutical stocks, short…

Lee Jackson | Jul 8, 2015 at 8:55 AM EDT

3 UBS Must-Own Large-Cap Pharmaceutical Stocks

A new report from UBS highlights three stocks that the firm likes best now. Not only do they all pay…

Chris Lange | Jun 26, 2015 at 11:35 AM EDT

Is Big Pharma Advertising Getting Out of Control?

How much are big pharmaceutical companies really spending to get their drugs out there in the public eye?

Chris Lange | Jun 25, 2015 at 8:10 AM EDT

Short Sellers Become More Focused on Big Pharma

The June 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short…

Lee Jackson | Jun 15, 2015 at 9:15 AM EDT

Jefferies Franchise Stock Picks Crush S&P 500: 4 to Buy Now

We screened the Jefferies Franchise Pick List for top stocks rated Buy with the highest upside to the Jefferies price…

Chris Lange | Jun 10, 2015 at 8:30 AM EDT

Short Sellers Back Off Big Pharma

The May 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Trey Thoelcke | Jun 10, 2015 at 6:49 AM EDT

The 6 Most Shorted NYSE Stocks in May

AT&T continued to reign as the most shorted stock trading on the New York Stock Exchange between the May 15…

Chris Lange | Jun 8, 2015 at 1:00 PM EDT

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

Credit Suisse has updated its autoimmune market model and it sees implications for all of the large cap U.S. pharmaceutical…

Chris Lange | Jun 3, 2015 at 10:30 AM EDT

How Halozyme Will Continue to Grow With Its New Deal

Halozyme Therapeutics has announced a global collaboration and license agreement with AbbVie.

Chris Lange | Jun 2, 2015 at 8:50 AM EDT

The 4 Overlooked Winners of ASCO

ThinkstockThe American Society of Clinical Oncology’s (ASCO) annual meeting is coming to a close. Companies and cancer drug developers across…

Chris Lange | May 28, 2015 at 9:30 AM EDT

Short Sellers More Selective on Big Pharma Stocks

The short interest data has been released for the May 15 settlement date and for the selected pharmaceutical stocks, short…

Jon C. Ogg | May 27, 2015 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Ambarella, eBay, Rite Aid, TiVo, Yahoo, Valero, Virtu and More

Wednesday's top analyst upgrades, downgrades and initiations include Ambarella, eBay, Rite Aid, TiVo, Yahoo, Valero Energy and Virtu Financial.

1 … 34 35 36 37 38 … 41

AbbVie : ABBV

All AbbVie Articles

What to Expect From AbbVie Earnings

Top Health Care Earnings for the Week Ahead

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

Short Sellers Run for Cover in Big Pharma

3 UBS Must-Own Large-Cap Pharmaceutical Stocks

Is Big Pharma Advertising Getting Out of Control?

Short Sellers Become More Focused on Big Pharma

Jefferies Franchise Stock Picks Crush S&P 500: 4 to Buy Now

Short Sellers Back Off Big Pharma

The 6 Most Shorted NYSE Stocks in May

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

How Halozyme Will Continue to Grow With Its New Deal

The 4 Overlooked Winners of ASCO

Short Sellers More Selective on Big Pharma Stocks

Top Analyst Upgrades and Downgrades: Ambarella, eBay, Rite Aid, TiVo, Yahoo, Valero, Virtu and More

Social Security’s Timetable for Collapse Just Moved Up – and That’s Not Even the Worst News

“He’s a Wolf in the Middle of the Sheep Pen”: Dave Ramsey to a Church Elder Watching a Fellow Member Sell Whole Life Insurance to Congregants

Here’s How You Can Retire to St. Petersburg, Florida, at 65 on $925,000 Where the Sun Shines

Social Security's Timetable for Collapse Just Moved Up - and That's Not Even the Worst News

"He's a Wolf in the Middle of the Sheep Pen": Dave Ramsey to a Church Elder Watching a Fellow Member Sell Whole Life Insurance to Congregants

Social Security’s Timetable for Collapse Just Moved Up – and That’s Not Even the Worst News

“He’s a Wolf in the Middle of the Sheep Pen”: Dave Ramsey to a Church Elder Watching a Fellow Member Sell Whole Life Insurance to Congregants

AbbVie : ABBV

All AbbVie Articles

What to Expect From AbbVie Earnings

Top Health Care Earnings for the Week Ahead

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

Short Sellers Run for Cover in Big Pharma

3 UBS Must-Own Large-Cap Pharmaceutical Stocks

Is Big Pharma Advertising Getting Out of Control?

Short Sellers Become More Focused on Big Pharma

Jefferies Franchise Stock Picks Crush S&P 500: 4 to Buy Now

Short Sellers Back Off Big Pharma

The 6 Most Shorted NYSE Stocks in May

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

How Halozyme Will Continue to Grow With Its New Deal

The 4 Overlooked Winners of ASCO

Short Sellers More Selective on Big Pharma Stocks

Top Analyst Upgrades and Downgrades: Ambarella, eBay, Rite Aid, TiVo, Yahoo, Valero, Virtu and More

Social Security’s Timetable for Collapse Just Moved Up – and That’s Not Even the Worst News

“He’s a Wolf in the Middle of the Sheep Pen”: Dave Ramsey to a Church Elder Watching a Fellow Member Sell Whole Life Insurance to Congregants

Here’s How You Can Retire to St. Petersburg, Florida, at 65 on $925,000 Where the Sun Shines

Featured Reads

Social Security's Timetable for Collapse Just Moved Up - and That's Not Even the Worst News

"He's a Wolf in the Middle of the Sheep Pen": Dave Ramsey to a Church Elder Watching a Fellow Member Sell Whole Life Insurance to Congregants